In conclusion, we established new models of Parkinson’s like neuroinflammation in human microglia in response to the mitochondrial inhibitors 6-OHDA and MPTP, as function of NF-κB in the latter, and the priming effect of IFN-γ plus boosted by high glucose treatment. Here, NFKB1 is linked to Parkinson disease.